title: Increased incidence of central nervous system hemorrhages in patients with secondary acute promyelocytic leukemia after treatment of multiple sclerosis with mitoxantrone?
authors.forename: Franziska
authors.initials: F
authors.lastname: Taube
authors.forename: Friedrich
authors.initials: F
authors.lastname: Stölzel
authors.forename: Christian
authors.initials: C
authors.lastname: Thiede
authors.forename: Gerhard
authors.initials: G
authors.lastname: Ehninger
authors.forename: Michael
authors.initials: M
authors.lastname: Laniado
authors.forename: Markus
authors.initials: M
authors.lastname: Schaich
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D020300:Intracranial Hemorrhages / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000209:etiology*; D015473:Leukemia, Promyelocytic, Acute / Q000139:chemically induced* / Q000150:complications*; D008875:Middle Aged; D008942:Mitoxantrone / Q000009:adverse effects* / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000150:complications* / Q000188:drug therapy*; D011859:Radiography; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D008942:Mitoxantrone